Original BARK (NYSE:BARK) reported quarterly losses of $(0.09) per share which met the analyst consensus estimate. This is a 25 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $134.33 million which beat the analyst consensus estimate of $134.23 million by 0.08 percent. This is a 4.60 percent decrease over sales of $140.81 million the same period last year.
Syndax Pharmaceuticals Q2 EPS $(0.44) Beats $(0.71) Estimate, Sales $379.00K Beat $220.00K Estimate
Syndax Pharmaceuticals (NASDAQ:SNDX) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.71) by 38.03 percent. This is a 4.76 percent decrease over losses of $(0.42) per share
